Brookfield再生能源

CBIO NASDAQ
8.27
-0.18
-2.13%
盘后: 8.29 +0.02 +0.24% 16:14 07/19 EDT
开盘
8.48
昨收
8.45
最高
8.57
最低
8.26
成交量
11.42万
成交均量(3M)
21.57万
52周最高
11.44
52周最低
6.20
换手率
0.95%
市值
9,907.55万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Brookfield再生能源 CBIO股票价格,Brookfield再生能源股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Catalyst Biosciences, Inc., formerly Targacept, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on creating and developing medicines to address serious medical conditions. The Company focuses its product development efforts in the fields of hemostasis, including the treatment of hemophilia and surgical bleeding, and inflammation, including prevention of delayed graft function (DGF) in renal transplants and the treatment of dry age-related macular degeneration (dry AMD), a condition that can cause visual impairment or blindness. The Company's advanced program is a coagulation Factor VIIa variant, CB 813d, that has completed a Phase I clinical trial in severe hemophilia A and B patients. In addition to its lead Factor VIIa program, it has approximately two other coagulation factors, a Factor IX variant, CB 2679d/ISU 304, that is in advanced preclinical development, and a Factor Xa variant that has reached the advanced lead preclinical-stage of development.
展开 >

最近浏览

名称
价格
涨跌幅